Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long-term Asthma Control Medication Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Inhaled Type
1.2.3 Oral Type
1.2.4 Intravenous Injection Type
1.3 Market by Application
1.3.1 Global Long-term Asthma Control Medication Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Long-term Asthma Control Medication Market Perspective (2018-2033)
2.2 Long-term Asthma Control Medication Growth Trends by Region
2.2.1 Global Long-term Asthma Control Medication Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Long-term Asthma Control Medication Historic Market Size by Region (2018-2023)
2.2.3 Long-term Asthma Control Medication Forecasted Market Size by Region (2024-2033)
2.3 Long-term Asthma Control Medication Market Dynamics
2.3.1 Long-term Asthma Control Medication Industry Trends
2.3.2 Long-term Asthma Control Medication Market Drivers
2.3.3 Long-term Asthma Control Medication Market Challenges
2.3.4 Long-term Asthma Control Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long-term Asthma Control Medication Players by Revenue
3.1.1 Global Top Long-term Asthma Control Medication Players by Revenue (2018-2023)
3.1.2 Global Long-term Asthma Control Medication Revenue Market Share by Players (2018-2023)
3.2 Global Long-term Asthma Control Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Long-term Asthma Control Medication Revenue
3.4 Global Long-term Asthma Control Medication Market Concentration Ratio
3.4.1 Global Long-term Asthma Control Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long-term Asthma Control Medication Revenue in 2022
3.5 Long-term Asthma Control Medication Key Players Head office and Area Served
3.6 Key Players Long-term Asthma Control Medication Product Solution and Service
3.7 Date of Enter into Long-term Asthma Control Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Long-term Asthma Control Medication Breakdown Data by Type
4.1 Global Long-term Asthma Control Medication Historic Market Size by Type (2018-2023)
4.2 Global Long-term Asthma Control Medication Forecasted Market Size by Type (2024-2033)
5 Long-term Asthma Control Medication Breakdown Data by Application
5.1 Global Long-term Asthma Control Medication Historic Market Size by Application (2018-2023)
5.2 Global Long-term Asthma Control Medication Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Long-term Asthma Control Medication Market Size (2018-2033)
6.2 North America Long-term Asthma Control Medication Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Long-term Asthma Control Medication Market Size by Country (2018-2023)
6.4 North America Long-term Asthma Control Medication Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Long-term Asthma Control Medication Market Size (2018-2033)
7.2 Europe Long-term Asthma Control Medication Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Long-term Asthma Control Medication Market Size by Country (2018-2023)
7.4 Europe Long-term Asthma Control Medication Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long-term Asthma Control Medication Market Size (2018-2033)
8.2 Asia-Pacific Long-term Asthma Control Medication Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Long-term Asthma Control Medication Market Size by Region (2018-2023)
8.4 Asia-Pacific Long-term Asthma Control Medication Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Long-term Asthma Control Medication Market Size (2018-2033)
9.2 Latin America Long-term Asthma Control Medication Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Long-term Asthma Control Medication Market Size by Country (2018-2023)
9.4 Latin America Long-term Asthma Control Medication Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long-term Asthma Control Medication Market Size (2018-2033)
10.2 Middle East & Africa Long-term Asthma Control Medication Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Long-term Asthma Control Medication Market Size by Country (2018-2023)
10.4 Middle East & Africa Long-term Asthma Control Medication Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Long-term Asthma Control Medication Introduction
11.1.4 Boehringer Ingelheim Revenue in Long-term Asthma Control Medication Business (2018-2023)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Mylan
11.2.1 Mylan Company Detail
11.2.2 Mylan Business Overview
11.2.3 Mylan Long-term Asthma Control Medication Introduction
11.2.4 Mylan Revenue in Long-term Asthma Control Medication Business (2018-2023)
11.2.5 Mylan Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Long-term Asthma Control Medication Introduction
11.3.4 GlaxoSmithKline Revenue in Long-term Asthma Control Medication Business (2018-2023)
11.3.5 GlaxoSmithKline Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Long-term Asthma Control Medication Introduction
11.4.4 AstraZeneca Revenue in Long-term Asthma Control Medication Business (2018-2023)
11.4.5 AstraZeneca Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Detail
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Long-term Asthma Control Medication Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Long-term Asthma Control Medication Business (2018-2023)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Merck & Co., Inc
11.6.1 Merck & Co., Inc Company Detail
11.6.2 Merck & Co., Inc Business Overview
11.6.3 Merck & Co., Inc Long-term Asthma Control Medication Introduction
11.6.4 Merck & Co., Inc Revenue in Long-term Asthma Control Medication Business (2018-2023)
11.6.5 Merck & Co., Inc Recent Development
11.7 Glenmark Pharmaceuticals
11.7.1 Glenmark Pharmaceuticals Company Detail
11.7.2 Glenmark Pharmaceuticals Business Overview
11.7.3 Glenmark Pharmaceuticals Long-term Asthma Control Medication Introduction
11.7.4 Glenmark Pharmaceuticals Revenue in Long-term Asthma Control Medication Business (2018-2023)
11.7.5 Glenmark Pharmaceuticals Recent Development
11.8 Teva Pharmaceutical Industries
11.8.1 Teva Pharmaceutical Industries Company Detail
11.8.2 Teva Pharmaceutical Industries Business Overview
11.8.3 Teva Pharmaceutical Industries Long-term Asthma Control Medication Introduction
11.8.4 Teva Pharmaceutical Industries Revenue in Long-term Asthma Control Medication Business (2018-2023)
11.8.5 Teva Pharmaceutical Industries Recent Development
11.9 Lupin Pharmaceuticals
11.9.1 Lupin Pharmaceuticals Company Detail
11.9.2 Lupin Pharmaceuticals Business Overview
11.9.3 Lupin Pharmaceuticals Long-term Asthma Control Medication Introduction
11.9.4 Lupin Pharmaceuticals Revenue in Long-term Asthma Control Medication Business (2018-2023)
11.9.5 Lupin Pharmaceuticals Recent Development
11.10 Novartis International AG
11.10.1 Novartis International AG Company Detail
11.10.2 Novartis International AG Business Overview
11.10.3 Novartis International AG Long-term Asthma Control Medication Introduction
11.10.4 Novartis International AG Revenue in Long-term Asthma Control Medication Business (2018-2023)
11.10.5 Novartis International AG Recent Development
11.11 Sunovion Pharmaceuticals
11.11.1 Sunovion Pharmaceuticals Company Detail
11.11.2 Sunovion Pharmaceuticals Business Overview
11.11.3 Sunovion Pharmaceuticals Long-term Asthma Control Medication Introduction
11.11.4 Sunovion Pharmaceuticals Revenue in Long-term Asthma Control Medication Business (2018-2023)
11.11.5 Sunovion Pharmaceuticals Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Long-term Asthma Control Medication Introduction
11.12.4 Sanofi Revenue in Long-term Asthma Control Medication Business (2018-2023)
11.12.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Long-term Asthma Control Medication Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Inhaled Type
Table 3. Key Players of Oral Type
Table 4. Key Players of Intravenous Injection Type
Table 5. Global Long-term Asthma Control Medication Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Long-term Asthma Control Medication Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Long-term Asthma Control Medication Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Long-term Asthma Control Medication Market Share by Region (2018-2023)
Table 9. Global Long-term Asthma Control Medication Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Long-term Asthma Control Medication Market Share by Region (2024-2033)
Table 11. Long-term Asthma Control Medication Market Trends
Table 12. Long-term Asthma Control Medication Market Drivers
Table 13. Long-term Asthma Control Medication Market Challenges
Table 14. Long-term Asthma Control Medication Market Restraints
Table 15. Global Long-term Asthma Control Medication Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Long-term Asthma Control Medication Market Share by Players (2018-2023)
Table 17. Global Top Long-term Asthma Control Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-term Asthma Control Medication as of 2022)
Table 18. Ranking of Global Top Long-term Asthma Control Medication Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Long-term Asthma Control Medication Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Long-term Asthma Control Medication Product Solution and Service
Table 22. Date of Enter into Long-term Asthma Control Medication Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Long-term Asthma Control Medication Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Long-term Asthma Control Medication Revenue Market Share by Type (2018-2023)
Table 26. Global Long-term Asthma Control Medication Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Long-term Asthma Control Medication Revenue Market Share by Type (2024-2033)
Table 28. Global Long-term Asthma Control Medication Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Long-term Asthma Control Medication Revenue Market Share by Application (2018-2023)
Table 30. Global Long-term Asthma Control Medication Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Long-term Asthma Control Medication Revenue Market Share by Application (2024-2033)
Table 32. North America Long-term Asthma Control Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Long-term Asthma Control Medication Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Long-term Asthma Control Medication Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Long-term Asthma Control Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Long-term Asthma Control Medication Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Long-term Asthma Control Medication Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Long-term Asthma Control Medication Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Long-term Asthma Control Medication Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Long-term Asthma Control Medication Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Long-term Asthma Control Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Long-term Asthma Control Medication Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Long-term Asthma Control Medication Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Long-term Asthma Control Medication Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Long-term Asthma Control Medication Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Long-term Asthma Control Medication Market Size by Country (2024-2033) & (US$ Million)
Table 47. Boehringer Ingelheim Company Detail
Table 48. Boehringer Ingelheim Business Overview
Table 49. Boehringer Ingelheim Long-term Asthma Control Medication Product
Table 50. Boehringer Ingelheim Revenue in Long-term Asthma Control Medication Business (2018-2023) & (US$ Million)
Table 51. Boehringer Ingelheim Recent Development
Table 52. Mylan Company Detail
Table 53. Mylan Business Overview
Table 54. Mylan Long-term Asthma Control Medication Product
Table 55. Mylan Revenue in Long-term Asthma Control Medication Business (2018-2023) & (US$ Million)
Table 56. Mylan Recent Development
Table 57. GlaxoSmithKline Company Detail
Table 58. GlaxoSmithKline Business Overview
Table 59. GlaxoSmithKline Long-term Asthma Control Medication Product
Table 60. GlaxoSmithKline Revenue in Long-term Asthma Control Medication Business (2018-2023) & (US$ Million)
Table 61. GlaxoSmithKline Recent Development
Table 62. AstraZeneca Company Detail
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Long-term Asthma Control Medication Product
Table 65. AstraZeneca Revenue in Long-term Asthma Control Medication Business (2018-2023) & (US$ Million)
Table 66. AstraZeneca Recent Development
Table 67. F. Hoffmann-La Roche Company Detail
Table 68. F. Hoffmann-La Roche Business Overview
Table 69. F. Hoffmann-La Roche Long-term Asthma Control Medication Product
Table 70. F. Hoffmann-La Roche Revenue in Long-term Asthma Control Medication Business (2018-2023) & (US$ Million)
Table 71. F. Hoffmann-La Roche Recent Development
Table 72. Merck & Co., Inc Company Detail
Table 73. Merck & Co., Inc Business Overview
Table 74. Merck & Co., Inc Long-term Asthma Control Medication Product
Table 75. Merck & Co., Inc Revenue in Long-term Asthma Control Medication Business (2018-2023) & (US$ Million)
Table 76. Merck & Co., Inc Recent Development
Table 77. Glenmark Pharmaceuticals Company Detail
Table 78. Glenmark Pharmaceuticals Business Overview
Table 79. Glenmark Pharmaceuticals Long-term Asthma Control Medication Product
Table 80. Glenmark Pharmaceuticals Revenue in Long-term Asthma Control Medication Business (2018-2023) & (US$ Million)
Table 81. Glenmark Pharmaceuticals Recent Development
Table 82. Teva Pharmaceutical Industries Company Detail
Table 83. Teva Pharmaceutical Industries Business Overview
Table 84. Teva Pharmaceutical Industries Long-term Asthma Control Medication Product
Table 85. Teva Pharmaceutical Industries Revenue in Long-term Asthma Control Medication Business (2018-2023) & (US$ Million)
Table 86. Teva Pharmaceutical Industries Recent Development
Table 87. Lupin Pharmaceuticals Company Detail
Table 88. Lupin Pharmaceuticals Business Overview
Table 89. Lupin Pharmaceuticals Long-term Asthma Control Medication Product
Table 90. Lupin Pharmaceuticals Revenue in Long-term Asthma Control Medication Business (2018-2023) & (US$ Million)
Table 91. Lupin Pharmaceuticals Recent Development
Table 92. Novartis International AG Company Detail
Table 93. Novartis International AG Business Overview
Table 94. Novartis International AG Long-term Asthma Control Medication Product
Table 95. Novartis International AG Revenue in Long-term Asthma Control Medication Business (2018-2023) & (US$ Million)
Table 96. Novartis International AG Recent Development
Table 97. Sunovion Pharmaceuticals Company Detail
Table 98. Sunovion Pharmaceuticals Business Overview
Table 99. Sunovion Pharmaceuticals Long-term Asthma Control Medication Product
Table 100. Sunovion Pharmaceuticals Revenue in Long-term Asthma Control Medication Business (2018-2023) & (US$ Million)
Table 101. Sunovion Pharmaceuticals Recent Development
Table 102. Sanofi Company Detail
Table 103. Sanofi Business Overview
Table 104. Sanofi Long-term Asthma Control Medication Product
Table 105. Sanofi Revenue in Long-term Asthma Control Medication Business (2018-2023) & (US$ Million)
Table 106. Sanofi Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long-term Asthma Control Medication Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Long-term Asthma Control Medication Market Share by Type: 2022 VS 2033
Figure 3. Inhaled Type Features
Figure 4. Oral Type Features
Figure 5. Intravenous Injection Type Features
Figure 6. Global Long-term Asthma Control Medication Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Long-term Asthma Control Medication Market Share by Application: 2022 VS 2033
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Pharmacy Case Studies
Figure 11. Long-term Asthma Control Medication Report Years Considered
Figure 12. Global Long-term Asthma Control Medication Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Long-term Asthma Control Medication Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Long-term Asthma Control Medication Market Share by Region: 2022 VS 2033
Figure 15. Global Long-term Asthma Control Medication Market Share by Players in 2022
Figure 16. Global Top Long-term Asthma Control Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-term Asthma Control Medication as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Long-term Asthma Control Medication Revenue in 2022
Figure 18. North America Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Long-term Asthma Control Medication Market Share by Country (2018-2033)
Figure 20. United States Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Long-term Asthma Control Medication Market Share by Country (2018-2033)
Figure 24. Germany Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Long-term Asthma Control Medication Market Share by Region (2018-2033)
Figure 32. China Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Long-term Asthma Control Medication Market Share by Country (2018-2033)
Figure 40. Mexico Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Long-term Asthma Control Medication Market Share by Country (2018-2033)
Figure 44. Turkey Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Long-term Asthma Control Medication Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Boehringer Ingelheim Revenue Growth Rate in Long-term Asthma Control Medication Business (2018-2023)
Figure 47. Mylan Revenue Growth Rate in Long-term Asthma Control Medication Business (2018-2023)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Long-term Asthma Control Medication Business (2018-2023)
Figure 49. AstraZeneca Revenue Growth Rate in Long-term Asthma Control Medication Business (2018-2023)
Figure 50. F. Hoffmann-La Roche Revenue Growth Rate in Long-term Asthma Control Medication Business (2018-2023)
Figure 51. Merck & Co., Inc Revenue Growth Rate in Long-term Asthma Control Medication Business (2018-2023)
Figure 52. Glenmark Pharmaceuticals Revenue Growth Rate in Long-term Asthma Control Medication Business (2018-2023)
Figure 53. Teva Pharmaceutical Industries Revenue Growth Rate in Long-term Asthma Control Medication Business (2018-2023)
Figure 54. Lupin Pharmaceuticals Revenue Growth Rate in Long-term Asthma Control Medication Business (2018-2023)
Figure 55. Novartis International AG Revenue Growth Rate in Long-term Asthma Control Medication Business (2018-2023)
Figure 56. Sunovion Pharmaceuticals Revenue Growth Rate in Long-term Asthma Control Medication Business (2018-2023)
Figure 57. Sanofi Revenue Growth Rate in Long-term Asthma Control Medication Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed